Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123653832 | 12365383 | 2 | F | 2013 | 20160804 | 20160513 | 20160809 | EXP | IE-PFIZER INC-2016248524 | PFIZER | 8.00 | YR | F | Y | 0.00000 | 20160809 | CN | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123653832 | 12365383 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | 0.75 MG, ONCE A DAY FOR 6 DAYS | U | 20280 | .75 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123653832 | 12365383 | 1 | Blood growth hormone |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123653832 | 12365383 | OT |
| 123653832 | 12365383 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123653832 | 12365383 | Emotional disorder | |
| 123653832 | 12365383 | Epistaxis | |
| 123653832 | 12365383 | Hernia | |
| 123653832 | 12365383 | Malaise | |
| 123653832 | 12365383 | Melanocytic naevus | |
| 123653832 | 12365383 | Precocious puberty | |
| 123653832 | 12365383 | Sleep disorder | |
| 123653832 | 12365383 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123653832 | 12365383 | 1 | 201204 | 0 |